Imeik Technology Development Co Ltd
SZSE:300896

Watchlist Manager
Imeik Technology Development Co Ltd Logo
Imeik Technology Development Co Ltd
SZSE:300896
Watchlist
Price: 204.57 CNY -4.27% Market Closed
Market Cap: 62B CNY
Have any thoughts about
Imeik Technology Development Co Ltd?
Write Note

Relative Value

The Relative Value of one Imeik Technology Development Co Ltd stock under the Base Case scenario is 197.17 CNY. Compared to the current market price of 204.57 CNY, Imeik Technology Development Co Ltd is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
197.17 CNY
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
84
vs Industry
29
Median 3Y
39.3
Median 5Y
41.6
Industry
7.7
Forward
18.4
vs History
86
vs Industry
5
Median 3Y
60.5
Median 5Y
64.8
Industry
22.7
Forward
29
vs History
82
vs Industry
5
Median 3Y
56.4
Median 5Y
61
Industry
21.6
vs History
82
vs Industry
4
Median 3Y
59
Median 5Y
66
Industry
25.2
vs History
78
vs Industry
10
Median 3Y
12.4
Median 5Y
13.2
Industry
2.5
vs History
82
vs Industry
26
Median 3Y
37.3
Median 5Y
39
Industry
7.7
Forward
17.2
vs History
82
vs Industry
23
Median 3Y
39.7
Median 5Y
41.4
Industry
9
vs History
86
vs Industry
3
Median 3Y
51.7
Median 5Y
54.3
Industry
4.2
Forward
23.3
vs History
86
vs Industry
4
Median 3Y
51.7
Median 5Y
54.3
Industry
4.1
Forward
21.8
vs History
82
vs Industry
4
Median 3Y
53.3
Median 5Y
58.1
Industry
5.7
vs History
82
vs Industry
4
Median 3Y
55.7
Median 5Y
62.8
Industry
3.6
vs History
82
vs Industry
15
Median 3Y
27.5
Median 5Y
35.9
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Imeik Technology Development Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Imeik Technology Development Co Ltd
SZSE:300896
61.9B CNY 20.1 30.5 25.5 25.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
Imeik Technology Development Co Ltd
SZSE:300896
Average P/E: 178.4
30.5
67%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Imeik Technology Development Co Ltd
SZSE:300896
Average EV/EBITDA: 18.4
25.5
68%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
Imeik Technology Development Co Ltd
SZSE:300896
Average EV/EBIT: 22.9
25.5
92%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top